Loopbaan van Jun Axup
Eerdere bekende functies van Jun Axup
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
SOSV Ltd.
 SOSV Ltd. Investment ManagersFinance Sosv Ltd (Sosv) is a multi-stage venture capital and accelerator firm founded by Sean O’Sullivan in 1994. The firm is headquartered in Ireland with an additional offices in Luxembourg, USA, Hong Kong and China. | Private Equity Investor | 01-08-2016 | 01-03-2022 |
Myi Diagnostics & Discovery, Inc.
 Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Operationeel Directeur | 01-11-2015 | 01-06-2016 |
| Oprichter | 01-11-2015 | 01-06-2016 |
Statistieken
Internationaal
| Ierland | 2 |
| Verenigde Staten | 2 |
Operationeel
| Private Equity Investor | 1 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Sectoraal
| Finance | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
SOSV Ltd.
SOSV Ltd. Investment ManagersFinance Sosv Ltd (Sosv) is a multi-stage venture capital and accelerator firm founded by Sean O’Sullivan in 1994. The firm is headquartered in Ireland with an additional offices in Luxembourg, USA, Hong Kong and China. | Finance |
Myi Diagnostics & Discovery, Inc.
Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Health Technology |
